386 related articles for article (PubMed ID: 19049844)
1. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
2. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy.
Sattar N; Greer IA; Rumley A; Stewart G; Shepherd J; Packard CJ; Lowe GD
Thromb Haemost; 1999 Jan; 81(1):71-5. PubMed ID: 9974378
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic parameters in patients with primitive venous hypertension.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
[TBL] [Abstract][Full Text] [Related]
7. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
Kvasnicka J; Skrha J; Perusicová J; Maslowská H; Pochopová L
Cas Lek Cesk; 1996 Mar; 135(6):174-7. PubMed ID: 8681360
[TBL] [Abstract][Full Text] [Related]
8. Prospective double-arm study of fibrinolysis in surgical patients.
Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
Choi JW; Pai SH
Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
[TBL] [Abstract][Full Text] [Related]
10. Haemostatic changes in patients with deep vein thrombosis.
Trifiletti A; Scamardi R; Pizzoleo MA; Soraci S; Nevoso A; Bagnato L; Barbera N
Panminerva Med; 1997 Mar; 39(1):21-3. PubMed ID: 9175416
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
Li F; Zhang G; Zhao W
Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
[TBL] [Abstract][Full Text] [Related]
12. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of the hemostasis parameters in the development of preeclampsia.
Ho CH; Yang ZL
Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
15. [Activation of fibrynolysis in children with chronic B or C hepatitis].
Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
[TBL] [Abstract][Full Text] [Related]
16. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
DeSouza CA; Jones PP; Seals DR
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
[TBL] [Abstract][Full Text] [Related]
17. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
18. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
19. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
20. Severe preeclampsia: are hemostatic and inflammatory parameters associated?
Pinheiro MB; Carvalho MG; Martins-Filho OA; Freitas LG; Godoi LC; Alpoim PN; Gomes KB; Dusse LM
Clin Chim Acta; 2014 Jan; 427():65-70. PubMed ID: 24121033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]